(Q43174441)

15 November 2017

ABCG2 polymorphism is associated with the low-density lipoprotein cholesterol response to rosuvastatin (English)

1 reference

15 November 2017

1 reference

8

1 reference

15 November 2017

B Tomlinson

1

1 reference

15 November 2017

M Hu

2

1 reference

15 November 2017

V W Y Lee

3

1 reference

15 November 2017

S S H Lui

4

1 reference

15 November 2017

T T W Chu

5

1 reference

15 November 2017

E W M Poon

6

1 reference

15 November 2017

G T C Ko

7

1 reference

15 November 2017

L S Tam

9

1 reference

15 November 2017

E K Li

10

1 reference

15 November 2017

language of work or name

English

0 references

publication date

3 February 2010

1 reference

Clinical Pharmacology & Therapeutics

15 November 2017

1 reference

15 November 2017

87

1 reference

15 November 2017

558-562

1 reference

15 November 2017

5

1 reference

Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths

15 November 2017

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.232

The issue of statin safety: where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.232

Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.232

Ethnic differences in statin disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.232

ATP-dependent transport of rosuvastatin in membrane vesicles expressing breast cancer resistance protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.232

ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.232

Identification and functional assessment of BCRP polymorphisms in a Korean population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.232

Functional analysis of SNPs variants of BCRP/ABCG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.232

Rosuvastatin: a new inhibitor of HMG-coA reductase for the treatment of dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.232

Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.232

Rosuvastatin--a highly effective new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor: review of clinical trial data at 10-40 mg doses in dyslipidemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.232

A randomised study comparing the efficacy and safety of rosuvastatin with atorvastatin for achieving lipid goals in clinical practice in Asian patients at high risk of cardiovascular disease (DISCOVERY-Asia study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.232

Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.232

SLCO1B1 (OATP1B1, an uptake transporter) and ABCG2 (BCRP, an efflux transporter) variant alleles and pharmacokinetics of pitavastatin in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.232

High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.232

Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.232

Influence of OATP1B1 genotype on the pharmacokinetics of rosuvastatin in Koreans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.232

Evaluation of inhibitory drug interactions during drug development: genetic polymorphisms must be considered

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.232

Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.232

SLCO1B1 variants and statin-induced myopathy--a genomewide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.232

Pharmacogenetics of HMG-CoA reductase inhibitors: exploring the potential for genotype-based individualization of coronary heart disease management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.232

Genetic and environmental factors affecting the response to statin therapy in patients with molecularly defined familial hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.232

Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.232

Different Effects of SLCO1B1 Polymorphism on the Pharmacokinetics of Atorvastatin and Rosuvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.232

Prospective evaluation of a stiff shaft glide wire compared with the standard straight wire in crossing severely stenotic aortic valves

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.232

inferred from DOI database lookup

7 January 2021

based on heuristic

Mutations in the low-density lipoprotein receptor gene in Chinese familial hypercholesterolemia patients

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.232

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CLPT.2009.232

1 reference

15 November 2017

1 reference